The Investigation of the Neonates With or With Risk of COVID-19

Status Completed

Clinical Trial Summary

Since December 2019, there has been an outbreak of novel coronavirus pneumonia in China. As of February 18, 2020, 72,530 cases confirmed with 2019 coronavirus disease(COVID-19) have been reported and 1,870 deaths were declared. Until now, cases of COVID-19 have been reported in 26 countries. This observational study aims to analysis the clinical features of neonates with COVID-19 and the neonates born to mother with COVID-19.

Clinical Trial Description

Given that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads rapidly and is contagious to the general population, all the suspected or confirmed newborns will be admitted to the neonatal departments in designated hospitals of China. In this study, the diagnosis of neonatal SARS-CoV-2 infection is based on the criterion provided by National Health Commission and the Chinese perinatal-neonatal SARS-CoV-2 Committee. All samples will be treated as biohazardous material. SARS-CoV-2 will be tested in blood, cord blood, amniotic fluid, placenta, respiratory tract, stool, urine from mothers or neonates. The medical information questionnaires are classified into maternal and neonatal version, which include demographic details, epidemical history, clinical manifestations, tests collected time and results, imaging performed time and results and therapeutic data. Two researchers independently checked and recorded the data to ensure the accuracy of the data. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04279899
Study type	Observational
Source	Children's Hospital of Fudan University
Contact
Status	Completed
Phase
Start date	February 1, 2020
Completion date	December 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05568953` - An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity	Phase 2
Completed	`NCT04568889` - Minnesota COVID-19 Testing Project	N/A
Completed	`NCT06063330` - Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects	Phase 1
Completed	`NCT01198925` - Assessment of the Optimal Dosing of Piperacillin-tazobactam in Intensive Care Unit Patients: Extended Versus Continuous Infusion	Phase 4
Completed	`NCT05063812` - Performance of a Remote Monitoring Program for Patients Diagnosed With COVID-19
Not yet recruiting	`NCT03636711` - Antibiotic Stewardship in Infectious Disease Departement
Completed	`NCT03457688` - Effect of Prebiotic Fructans to Reduce Number of Febrile Infections in Children	N/A
Completed	`NCT03241355` - Prebiotic Fructans on the Incidence of Acute Infectious Diseases in Children	N/A
Terminated	`NCT05420077` - Safety and Immunogenicity of RVM-V001 in Healthy Individuals Previously Vaccinated With BNT162b2 and mRNA-1273	Phase 1
Completed	`NCT04084106` - Effects of Phenoximethylpenicillin, Amoxicillin and Amoxicillin-clavulanic Acid on the Gut Microbiota	Phase 4
Recruiting	`NCT05013944` - AnovaOS Network Powered Patient Registry
Completed	`NCT03893279` - Perception of Smell and Taste During Antibiotic Treatment
Active, not recruiting	`NCT05619770` - Study to Evaluate Pharmacokinetics, Safety & Tolerability of 101-PGC-005 in Healthy, Adult, Human Subjects	Phase 1
Completed	`NCT01772901` - Brief Influenza Vaccine Education to Pregnant Women	N/A
Completed	`NCT05413772` - Temocillin in ESBL-Enterobacteriaceae Infections
Completed	`NCT04319328` - Is Cefazolin, Ceftazidime and Ciprofloxacin Dosing Optimal in Hemodialysis Patients?
Completed	`NCT04613271` - Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia	Phase 3
Completed	`NCT03239665` - Vaccination Education Through Pharmacists and Senior Centers (VEPSC)	N/A
Completed	`NCT03224026` - Validation of a Proteomic Signature and Assessment of Viremia in Children With Fever Without Source
Not yet recruiting	`NCT06102070` - Genetic Susceptibility to Severe Infections